About the Authors
- Francesco Berlanda Scorza
-
Current address: Novartis Vaccines and Diagnostics, Siena, Italy
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Anna Maria Colucci
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Luana Maggiore
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Silvia Sanzone
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Omar Rossi
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Ilaria Ferlenghi
-
Affiliation Novartis Vaccines and Diagnostics, Siena, Italy
- Isabella Pesce
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Mariaelena Caboni
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Nathalie Norais
-
Affiliation Novartis Vaccines and Diagnostics, Siena, Italy
- Vito Di Cioccio
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Allan Saul
-
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
- Christiane Gerke
-
* E-mail: christiane.gerke@novartis.com
Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy
Competing Interests
The authors have read the journal’s policy and have the following conflicts: Francesco Berlanda Scorza, Anna Maria Colucci, Luana Maggiore, Silvia Sanzone, Omar Rossi, Isabella Pesce, Mariaelena Caboni, Vito Di Cioccio, Allan Saul, and Christiane Gerke are or were at the time the study was conducted employees of Novartis Vaccines Institute for Global Health, Siena, Italy. Ilaria Ferlenghi and Nathalie Norais are employees of Novartis Vaccines and Diagnostics, Siena, Italy. The submitted work is included in the patent applications ‘Hyperblebbing Shigella strains’ WO/2011/036564 and ‘Purification of bacterial vesicles’ WO/2011/036562 submitted by Novartis Vaccines Institute for Global Health. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: FBS AMC SS NN VDC AS CG. Performed the experiments: FBS AMC LM SS OR IF IP MC VDC. Analyzed the data: FBS LM SS OR IF IP CG. Contributed reagents/materials/analysis tools: IF NN. Wrote the paper: FBS CG.